New Leaders of CDC’s HIV and TB Divisions Named

Content From: Jonathan Mermin, M.D., M.P.H., RADM and Assistant Surgeon General, USPHS, Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and PreventionPublished: July 31, 20144 min read


Eugene McCray, MD
Eugene McCray, MD
Philip LoBue, MD
Philip LoBue, MD
Two new Division Directors will begin their tenure at the Centers for Disease Control and Prevention’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP) on August 11.

Eugene McCray, MD, is the new Director of NCHHSTP’s Division of HIV/AIDS Prevention (DHAP). In this capacity, he will lead the Division’s work to promote health and quality of life by preventing HIV infection and reducing HIV-related illness and death in the United States and will oversee CDC’s work in support of the National HIV/AIDS Strategy (NHAS). Dr. McCray brings to DHAP many years of domestic and global experience in HIV and TB prevention and decades of service improving the health of underserved communities both in the United States and globally. Dr. McCray has directed and developed epidemiological, programmatic, and research activities, as well as facilitated collaboration across CDC, with other US government agencies, multilateral and international agencies, and Ministries of Health.

Dr. McCray began his career at CDC in 1983 as an Epidemic Intelligence Service officer and was most recently the Chief of the International Research and Programs Branch in CDC’s Division of TB Elimination (DTBE). He also was instrumental in CDC’s efforts from the early years of the HIV epidemic, helping to stand up and then lead CDC’s Global AIDS Program from 2000 to 2004. In addition, he served as the Acting Deputy Director in the Coordinating Office for Global Health (now the Center for Global Health) from 2004 to 2007.

Dr. McCray completed his clinical training in internal medicine at North Carolina Memorial Hospital, University of North Carolina-Chapel Hill, in 1983 and an Infectious Diseases Fellowship in 1992 at the University of Washington Medical Center, Seattle, Washington. He earned his Medical Degree from the Bowman Gray School of Medicine at Wake Forest University and his Bachelor of Science degree in biology from Morehouse College. Dr. McCray has authored or co-authored more than 60 scholarly articles and has received numerous awards for his scientific and public health contributions, including the U.S. Public Health Service’s (PHS) highest honor award, the PHS Distinguished Service Medal, and CDC’s William C. Watson Medal of Excellence award.

Also announced, Philip LoBue, MD is the new Director of DTBE and will lead the Division’s efforts to prevent, control, and eventually eliminate tuberculosis from the United States as well as collaborate with other countries and international partners in controlling global tuberculosis. DTBE staff carries out 10 core activities to fulfill their mission.

Dr. LoBue, has served as the Acting Director of DTBE for past last 11 months. Prior to this, he served as the Associate Director for Science at DTBE since 2006. Dr. LoBue began his CDC career in 1999 as a Field Medical Officer and Epidemiologist assigned to the San Diego County TB Control Program. In 2004, he moved to CDC headquarters in Atlanta to become Chief of DTBE’s Medical Consultation Team. Dr. LoBue’s 15 years of experience working in TB control, his scientific acumen, management expertise, and program leadership experience are invaluable assets for the Division and all of us working in the field of TB elimination. Dr. LoBue has been recognized for his leadership, receiving CDC’s Award for Excellence in Surveillance and Health Monitoring and the U.S. Food and Drug Administration’s Award for Outstanding Service.

Dr. LoBue earned his undergraduate and medical degrees from the University of Pennsylvania and completed his pulmonary and critical care fellowship in 1995 at the University of California (UC) San Diego Medical Center. He also subsequently served as an Assistant Clinical Professor of Medicine at UC San Diego. He is board certified in pulmonary medicine and critical care medicine, and he has authored or co-authored over 70 scientific papers and book chapters, including many on the impact of new technologies and the changing epidemiology of tuberculosis. He is a member of the International Union Against Tuberculosis and Lung Disease, the American Thoracic Society, and several World Health Organization committees and working groups.

Please join me in welcoming Drs. McCray and LoBue to their new leadership roles at CDC.